CXCL10 and myositis disease: CXCL10 has been recognized as a biomarker in several human autoimmune diseases, including myositis 29, 30, 31, 32, 33, whereas galectin‐9 has been investigated mainly as a biomarker in cancer and viral infections 28, 34.